Sernova Corp Appoints Interim CFO, Advances Innovation
Company Announcements

Sernova Corp Appoints Interim CFO, Advances Innovation

Sernova Corp (TSE:SVA) has released an update.

Sernova Corp has announced the appointment of interim CFO Nicholas J. Rossettos, while actively seeking a permanent CFO and other key leadership positions to advance its strategic goals. The company is dealing with internal investigations, resulting in the termination of previous CFO David Swetlow for cause, but confirms these issues will not materially affect financial statements. Sernova continues to innovate in regenerative medicine, aiming to transform patient lives with their Cell Pouch System and partnerships for cell therapy treatments.

For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskSernova Bolsters Leadership for Bio-hybrid Organ Programs
TipRanks Canadian Auto-Generated NewsdeskSernova Highlights Cell Therapy Advances at Industry Conference
TipRanks Canadian Auto-Generated NewsdeskSernova Strengthens Board with Biotech Expertise
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App